Daily vitamin pills may sharpen teen minds and strengthen bones, large trial tests

NCT ID NCT07695883

First seen Jul 10, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This trial tests whether giving adolescent girls a daily multiple micronutrient supplement (with or without extra nutrients) improves their growth, brain function, bone health, and overall well-being compared to the standard weekly iron-folic acid pill. About 3,000 girls aged 10–18 in rural Bangladesh will take the supplements for one year. The goal is to see if a simple daily pill can help teens in low-resource settings reach their full potential.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multiple micronutrient supplement (UNIMMAP formulation) with or without additional nutrients
What this could lead to
If effective, daily multiple micronutrient supplements could become a standard policy to improve growth, learning, and bone health in adolescent girls in low-resource settings.
What could go wrong
This is a single trial in one rural area of Bangladesh, so results may not apply elsewhere. Supplements may not show clear benefits over weekly iron-folic acid, and side effects from high-dose nutrients are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • JiVitA Project Head Quarters

    Rangpur City, Bangladesh

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.